Abstract
Purpose
Ahmed glaucoma valve (AGV) is an effective treatment method for refractory glaucoma (RG), however, additional surgical interventions may be required over the course of follow-up due to complications. Our aim is to investigate the causes, types, and outcomes of revisional surgical interventions apart from revisions aiming IOP control, following AGV implantation in patients with RG.
Methods
The pre- and postoperative month 1–3-6–12 and last visit examination findings of the patients who underwent various surgical revisions of AGV between January 2015 and April 2018 in our clinic were recorded, as well as the interval between AGV implantation-revision surgery and the presence of any other complications necessitating additional surgery. The success criteria were defined on the basis of need for additional procedures.
Results
Twenty-six eyes of 24 patients were included. The follow-up time and the interval between AGV implantation-surgical revisions were median 12 (6–92) and median 9.7 (1–72) months, respectively. The most common complication requiring revision was tube exposure in 15 (57.7%) followed by tube malposition in 11 (42.3%) eyes. Further interventions were required only in one eye with recurrent exposure.
Conclusion
AGV implantation has early and late tube-related complications necessitating revisional surgical interventions; which makes it important to have extended follow-up period for patients with AGV implants. Revisional interventions for AGV implants with tube-related complications are efficient procedures for the majority of patients, but recurrence may occur requiring additional revisions.
Similar content being viewed by others
Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.
References
Minckler DS, Francis BA, Hodapp EA, Jampel HD, Lin SC, Samples JR et al (2008) Aqueous shunts in Glaucoma. A report by the American Academy of Ophthalmology. Ophthalmology 115:1089–1098
Gandham SB, Costa VP, Katz LJ, Wilson RP, Sivalingam A, Belmont J, Smith M (1993) Aqueous tube-shunt implantation and pars plana vitrectomy in eyes with refractory glaucoma. Am J Ophthalmol 116(2):189–195
Budenz DL, Feuer WJ, Barton K, Schiffman J, Costa VP, Godfrey DG et al (2016) Postoperative complications in the Ahmed Baerveldt Comparison Study during Five Years of Follow-up. Am J Ophthalmol 163:75–82.e3
Budenz DL, Barton K, Gedde SJ, Feuer WJ, Schiffman J, Costa VP et al (2015) Five-year treatment outcomes in the ahmed baerveldt comparison study. Ophthalmology 122(2):308–316
Christakis PG, Kalenak JW, Tsai JC, Zurakowski D, Kammer JA, Harasymowycz PJ et al (2016) The Ahmed Versus Baerveldt study: five-year treatment outcomes. Ophthalmology 23:2093–2102
Tsai JC, Grajewski AL, Parrish RK (1999) Surgical revision of glaucoma shunt implants. Ophthalmic Surg Lasers 30(1):41–46
Chaku M, Netland PA, Ishida K, Rhee DJ (2016) Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery. Clin Ophthalmol 10: 547–553.
Ma KT, Kim JH, Seong GJ, Jang DS, Kim CY (2014) Scleral fixation of Ahmed glaucoma valve tube tip for adjustment of cornea-touching malposition. Eye 28(1): 23–25
Lavin MJ, Franks WA, Wormald RPL, Hitchings RA (1992) Clinical risk factors for failure in glaucoma tube surgery: a comparison of three tube designs. Arch Ophthalmol 110(4):480–485
Thieme H, Choritz L, Hofmann-Rummelt C, Schloetzer-Schrehardt U, Kottler UB (2011) Histopathologic findings in early encapsulated blebs of young patients treated with the ahmed glaucoma valve. J Glaucoma 20:433–438
Bikbov MM, Khusnitdinov II (2016) The results of the use of ahmed valve in refractory glaucoma surgery. J Curr Glaucoma Pract 9(3):86–91
Topouzis F, Coleman AL, Choplin N, Bethlem MM, Hill R, Yu F et al (1999) Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol 127:27–33.
Low SAW, Rootman DB, Rootman DS, Trope GE (2012) Repair of eroded glaucoma drainage devices: mid-term outcomes. J Glaucoma 21(9):619–622
Huddleston SM, Feldman RM, Budenz DL, Bell NP, Lee DA, Chuang AZ et al (2013) Aqueous shunt exposure: a retrospective review of repair outcome. J Glaucoma 22(6):433–438
Geffen N, Buys YM, Smith M, Anraku A, Alasbali T, Rachmiel R et al (2014) Conjunctival complications related to ahmed glaucoma valve insertion. J Glaucoma 23(2):109–114
Smith MF, Doyle JW, Ticrney JW (2002) A comparison of glaucoma drainage implant tube coverage. J Glaucoma 11(2):143–147
Trubnik V, Zangalli C, Moster MR, Chia T, Ali M, Martinez P et al (2015) Evaluation of risk factors for Glaucoma drainage device-related erosions: a retrospective case-control study. J Glaucoma 24(7):498–502
Koval MS, El Sayyad FF, Bell NP, Chuang AZ, Lee DA, Hypes SM, Grover DS, Baker LA, Huddleston SM, Budenz DL, Feldman RM (2013) Risk factors for tube shunt exposure: a matched case-control study. J Ophthalmol 2013:196215
Byun YS, Lee NY, Park CK (2009) Risk factors of implant exposure outside the conjunctiva after Ahmed glaucoma valve implantation. Jpn J Ophthalmol 53(2):114–119
Lee EK, Yun YJ, Lee JE, Yim JH, Kim CS (2009) Changes in corneal endothelial cells after Ahmed Glaucoma Valve Implantation: 2-Year Follow-up. Am J Ophthalmol 148(3):361–367
Kim KN, Lee SB, Lee YH, Lee JJ, Lim HB, Kim CS (2016) Changes in corneal endothelial cell density and the cumulative risk of corneal decompensation after Ahmed glaucoma valve implantation. Br J Ophthalmol 100(7):933–938
Funding
The authors have no proprietary interest and no financial support was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Approval of Research Ethics Committee: University of Health Sciences Gaziosmanpasa Taksim Training and Research Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kirmaci Kabakci, A., Solmaz, B., Basarir, B. et al. Non-intraocular pressure-related revision surgeries after Ahmed glaucoma valve (AGV) implantation in refractory glaucoma. Int Ophthalmol 41, 3533–3538 (2021). https://doi.org/10.1007/s10792-021-01920-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-021-01920-z